J&J | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 25.58B 2.2B 2024-12
Abbott USD 23.15B 503M 2025-03
Amgen USD 29.03B 2.26B 2024-12
AstraZeneca USD 26.14B 312M 2025-03
Baxter International USD 8.85B 11M 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Becton, Dickinson and Co. USD 8.66B 1.81B 2024-12
Biogen USD 7.46B 626.3M 2024-12
Boston Scientific USD 6.92B 1.84B 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
CONMED USD 640.01M 992K 2024-12
Cooper Companies USD 1.99B 35.5M 2025-01
Dexcom USD 4.3B 38.6M 2024-12
Edwards Lifesciences USD 6.29B 442.3M 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Globus Medical USD 2.18B 120.73M 2024-12
Hologic USD 3.49B 329.7M 2024-12
Indivior 883M 44M 2025-03
Insulet USD 1.89B 30.4M 2024-12
Integra LifeSciences USD 1.08B 17.84M 2024-12
Intuitive Surgical USD 11.88B 331.3M 2025-03
J&J USD 71.55B 15.66B 2025-03
Medtronic USD 22.51B 75M 2025-01
Merck USD 38.78B 1.58B 2024-12
Merit Medical Systems USD 958.64M 34.86M 2025-03
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
Stryker USD 14.85B 174M 2024-12
Tandem Diabetes Care USD 663.44M 61.06M 2025-03
Teva Pharmaceutical Industries USD 12.55B 238M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12
Zimmer Biomet Holdings USD 4.67B 192.5M 2024-12
Zoetis USD 5.99B 296M 2024-12



J&J Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.